Subject Area
Plastic Surgery
Article Type
Original Study
Abstract
Objective This study was designed to assess hemoglobin A1c (HbA1c) levels in nondiabetic children with end-stage renal disease (ESRD) receiving regular hemodialysis (HD). Background HbA1c level represents an established tool to monitor glycemic control in diabetic patients. Patients and methods We enrolled 30 nondiabetic ESRD children receiving HD as a HD group and 30 healthy children as a control group for this study. All children were subjected to full history taking and physical examination. HbA1c, fasting blood glucose, hemoglobin level, hematocrit value, serum calcium, potassium, phosphate, blood urea nitrogen, creatinine, and parathormone hormone were measured in all participants. HbA1c level was measured by using the turbidimetric immunoassay method. Results We found a statistically significant difference as regards HbA1c (%) between cases and controls. In addition, there was no statistically significant difference in fasting blood glucose (mg/dl) between the two studied groups. Conclusion Our limited data indicate that HbA1c levels are elevated in nondiabetic ESRD patients receiving HD.
Recommended Citation
El-Gebally, El-Sayed I.; El-Mashad, Ghada M.; Talha, Hend G.; and Allam, Maha M.
(2018)
"Hemoglobin A1c level in nondiabetic children with end-stage renal disease receiving regular hemodialysis,"
Menoufia Medical Journal: Vol. 31:
Iss.
3, Article 44.
DOI: https://doi.org/10.4103/mmj.mmj_56_17
Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
